GLOBAL BLOOD THERAPEUTICS IN - PUT Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2022

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Price (Median)	Investors
2022 Q4	0	$0	-$8,758,000	$0		0
2022 Q3	128,600	$8,758,000	+$8,758,000	$15,433,000	$68.10	1
2022 Q2				$8,942,000	$31.95	0
2022 Q1				$1,347,000	$34.63	0
2021 Q4				$1,519,000	$29.27	0
2021 Q3				$1,261,000	$31.40	0
2021 Q2				$959,000	$34.98	0
2021 Q1				$5,301,000	$2056.85	0
2020 Q4				$15,652,000	$2187.06	0
2020 Q3				$4,664,000	$2758.34	0
2020 Q2				$4,879,000	$6000.00	0
2020 Q1				$7,280,000	$2578.74	0
2019 Q4				$18,478,000	$79.50	0
2019 Q3				$2,658,000	$48.52	0
2019 Q2				$8,842,000	$2656.09	0
2019 Q1				$1,693,000	$2671.36	0
2018 Q4				$3,234,000	$2069.20	0
2018 Q3				$5,495,000	$3799.11	0
2018 Q2				$9,329,000	$4517.24	0
2018 Q1				$2,709,000	$453.64	0
2017 Q4				$6,748,000	$39.36	0
2017 Q3				$391,000	$60.98	0
2017 Q2				$488,000	$267.09	0
2017 Q1				$631,000	$75.57	0
2016 Q4				$196,000	$285.62	0
2016 Q3				$5,289,000	$191.53	0
2016 Q2				$195,000	$16.57	0
2016 Q1				$5,000	$416.67	0